准代谢重编程以克服黑色素瘤免疫治疗中的免疫耐受性
Qinchen Wang1, Lei Shi1, Daoming Shi1
1Department of Burns and Plastic Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Frontiers in immunology
|June 20, 2025
概括
黑色素瘤免疫疗法耐药性是一个重大挑战. 本综述探讨了代谢变化,瘤微环境和肠道细菌如何促进耐药性,为更好的黑色素瘤治疗提出了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 免疫疗法显著推进了黑色素瘤治疗.
- 治疗耐药性仍然是一个关键的挑战,影响患者的治疗结果.
- 了解耐药机制对于改善黑色素瘤治疗至关重要.
研究的目的:
- 审查黑色素瘤免疫疗法耐药性的机制.
- 突出代谢途径,瘤微环境和肠道微生物群的作用.
- 识别潜在的克服阻力策略.
主要方法:
- 关于黑色素瘤免疫疗法耐药性的当前研究的文献综述.
- 对代谢重编程,瘤微环境变化和肠道微生物群影响的分析.
- 综合发现,提出治疗目标.
主要成果:
- 代谢重编程支持黑色素瘤的扩散和免疫逃避.
- 细胞外酸化和血管新生影响耐药性的发展.
- 肠道微生物群的组成影响治疗反应和耐药性.
结论:
- 针对代谢途径,瘤微环境和肠道微生物群是必不可少的.
- 克服多面性抵抗机制可以导致更有效的黑色素瘤治疗方法.
- 开发持久的治疗策略需要全面的方法.
相关概念视频
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K